Artesunate enhances radiosensitivity of human non-small cell lung cancer A549 cells via increasing NO production to induce cell cycle arrest at G 2/M phase

International Immunopharmacology

Volumn 11, Issue 12, 2011, Pages 2039-2046

  Zhao, Yanyan ^a   Jiang, Weiwei ^a   Li, Bin ^a   Yao, Qi ^a   Dong, Junqing ^a   Cen, Yanyan ^a   Pan, Xichun ^a   Li, Jun ^a   Zheng, Jiang ^a   Pang, Xueli ^a   Zhou, Hong ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Artesunate; Cell cycle arrest; Cyclin B1; NO; Radiosensitivity

Indexed keywords

ARTEMETHER; ARTEMISININ; ARTESUNATE; CYCLIN B1; DIHYDROARTEMISININ; MESSENGER RNA; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER RADIOTHERAPY; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG MECHANISM; DRUG SCREENING; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; IRRADIATION; LUNG NON SMALL CELL CANCER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; RADIOSENSITIZATION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; ARTEMISININS; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; CYCLIN B1; DOWN-REGULATION; HUMANS; LUNG NEOPLASMS; NITRIC OXIDE; RADIATION-SENSITIZING AGENTS;

EID: 81855168327     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.08.017     Document Type: Article

References (44)

1. J.H. Schiller Current standards of care in small-cell and non-small-cell lung cancer Oncol 61 2001 3 13
2. H.K. Weir, M.J. Thun, and B.F. Hankey Annual report to the nation on the status of cancer 1975-2000, featuring the uses of surveillance data for cancer prevention and control J Natl Cancer Inst 95 2003 1276 1299 (Pubitemid 37160862)
3. J. Carmichael, W.G. Degraff, J. Gamson, D. Russo, A.F. Gazdar, and M.L. Levitt Radiation sensitivity of human lung cancer cell lines Eur J Cancer Clin Oncol 25 1989 527 534 (Pubitemid 19061774)
4. G. Giaccone Clinical impact of novel treatment strategies Oncogene 21 2002 6970 6981 (Pubitemid 35221942)
5. D.O. Moon, M.O. Kim, Y.H. Choi, J.W. Hyun, W.Y. Chang, and G.Y. Kim Butein induces G2/M phase arrest and apoptosis in human hepatoma cancer cells through ROS generation Cancer Lett 288 2010 204 213
6. S. Baruchel, T. Wang, R. Farah, M. Jamali, and G. Batist In vivo selective modulation of tissue glutathione in a rat mammary carcinoma model Biochem Pharmacol 50 1995 1505 1508
7. F. Nosten, and R.N. Price New antimalarials: a risk-benefit analysis Drug Saf 12 1995 264 273
8. T. Efferth, and M. Volm Glutathione-related enzymes contribute to resistance of tumor cells and low toxicity in normal organs to artesunate In Vivo 19 2005 225 232 (Pubitemid 40450401)
9. T. Efferth Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells Curr Drug Targets 7 2006 407 421 (Pubitemid 43744832)
10. S.J. Kim, M.S. Kim, J.W. Lee, C.H. Lee, H. Yoo, and S.H. Shin Dihydroartemisinin enhances radiosensitivity of human glioma cells in vitro J Cancer Res Clin Oncol 132 2006 129 135
11. B. Pauwels, A.E. Korst, C.M. de Pooter, G.G. Pattyn, H.A. Lambrechts, and M.F. Baay Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studies Cancer Chemother Pharmacol 51 2003 221 226 (Pubitemid 36469951)
12. L. Tirand, T. Bastogne, D. Bechet, M. Linder, N. Thomas, and C. Frochot Response surface methodology: an extensive potential to optimize in vivo photodynamic therapy conditions Int J Radiat Oncol Biol Phys 75 2009 244 252
13. J. Romero, I. Zapata, S. Córdoba, J.M. Jimeno, J.A. López-Martín, and J.C. Tercero In vitro radiosensitisation by trabectedin in human cancer cell lines Eur J Cancer 44 2008 1726 1733
14. Weiwei Jiang, Bin Li, Xinchuan Zheng, Xin Liu, Yanyan Cen, and Jun Li Artesunate in combination with oxacillin protect sepsis model mice challenged with lethal live methicillin-resistant Staphylococcus aureus (MRSA) via its inhibition on proinflammatory cytokines release and enhancement on antibacterial activity of oxacillin Int Immunopharmacol 11 2011 1065 1073
15. V.B. Konkimalla, M. Blunder, B. Korn, S.A. Soomro, H. Jansen, and W. Chang Effect of artemisinins and other endoperoxides on nitric oxide-related signaling pathway in RAW 264.7 mouse macrophage cells Nitric Oxide 19 2008 184 191
16. Q.P. Zeng, and P.Z. Zhang Artesunate mitigates proliferation of tumor cells by alkylating heme-harboring nitric oxide synthase Nitric Oxide 24 2011 110 112
17. J.F. Jeannin, L. Leon, M. Cortier, N. Sassi, C. Paul, and A. Bettaieb Nitric oxide-induced resistance or sensitization to death in tumor cells Nitric Oxide 19 2008 158 163
18. M. Kato, T. Nonaka, M. Maki, H. Kikuchi, and S. Imajoh-Ohmi Caspases cleave the amino-terminal calpain inhibitory unit of calpastatin during apoptosis in human Jurkat T cells J Biochem 127 2000 297 305 (Pubitemid 30136913)
19. K. Arita, T. Utsumi, A. Kato, T. Kanno, H. Kobuchi, and B. Inoue Mechanism of dibucaine-induced apoptosis in promyelocytic leukemia cells (HL-60) Biochem Pharmacol 60 2000 905 915
20. Y. Jiao, C.M. Ge, Q.H. Meng, J.P. Cao, J. Tong, and S.J. Fan Dihydroartemisinin is an inhibitor of ovarian cancer cell growth Acta Pharmacol Sin 28 2007 1045 1056 (Pubitemid 47020494)
21. 2/M cell cycle progression of tumour cells and budding yeast Cancer Genomics Proteomics 7 2010 337 346
22. P. Nurse Universal control mechanism regulating onset of M-phase Nature 344 1990 503 508
23. N. Nomura, M. Nomura, E.W. Newcomb, and D. Zagzag Geldanamycin induces G2 arrest in U87MG glioblastoma cells through downregulation of cdc2 and cyclin B1 Biochem Pharmacol 73 2007 1528 1536 (Pubitemid 46527544)
24. N. Kaushal, and M.P. Bansal Dietary selenium variation-induced oxidative stress modulates CDC2/cyclin B1 expression and apoptosis of germ cells in mice testis J Nutr Biochem 18 2007 553 564 (Pubitemid 47043416)
25. 2 checkpoint through cyclin B1 Proc Natl Acad Sci U S A 96 1999 2147 2152 (Pubitemid 29117882)
26. G. Enikolopov, J. Banerji, and B. Kuzin Nitric oxide and Drosophila development Cell Death Differ 6 1999 956 963 (Pubitemid 29520796)
27. J.A. Wingrove, and P.H. O'Farrell Nitric oxide contributes to behavioral, cellular, and developmental responses to low oxygen in Drosophila Cell 98 1999 105 114 (Pubitemid 29331200)
28. H. Yasuda Solid tumor physiology and hypoxia-induced chemo/radio- resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer Nitric Oxide 19 2008 205 216
29. T. Efferth, M.M. Briehl, and M.E. Tome Role of antioxidant genes for the activity of artesunate against tumor cells Int J Oncol 23 2003 1231 1235
30. T. Efferth, A. Sauerbrey, A. Olbrich, E. Gebhart, P. Rauch, and H.O. Weber Molecular modes of action of artesunate in tumor cell lines Mol Pharmacol 64 2003 382 394 (Pubitemid 36910002)
31. T. Efferth, and F. Oesch Oxidative stress response of tumor cells: microarray-based comparison between artemisinins and anthracyclines Biochem Pharmacol 68 2004 3 10 (Pubitemid 38746536)
32. T. Efferth, A. Benakis, M.R. Romero, M. Tomicic, R. Rauh, and D. Steinbach Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron Free Radic Biol Med 37 2004 998 1009 (Pubitemid 39164582)
33. J.B. Mitchell, J.A. Cook, M.C. Krishna, W. DeGraffi, J. Gamson, and J. Fisher Radiation sensitisation by nitric oxide releasing agents Br J Cancer Suppl 27 1996 S181 S184
34. J.B. Mitchell, W. DeGraff, S. Kim, J.A. Cook, J. Gamson, and D. Christodoulou Redox generation of nitric oxide to radiosensitize hypoxic cells Int J Radiat Oncol Biol Phys 42 1998 795 798 (Pubitemid 28559419)
35. P. Wardman, K. Rothkamm, L.K. Folkes, M. Woodcock, and P.J. Johnston Radiosensitization by nitric oxide at low radiation doses Radiat Res 167 2007 475 484 (Pubitemid 351292978)
36. B.F. Jordan, N. Beghein, M. Aubry, V. Grégoire, and B. Gallez Potentiation of radiation-induced regrowth delay by isosorbide dinitrate in FSaII murine tumors Int J Cancer 103 2003 138 141 (Pubitemid 35424219)
37. A.G. Porter, and R.U. Jänicke Emerging roles of caspase 3 in apoptosis Cell Death Differ 6 1999 99 104
38. L. Zha, T. Qiao, S. Yuan, and L. Lei enhancement of radiosensitivity by CpG-oligodeoxyribonucleotide-7909 in human non-small cell lung cancer A549 cells Cancer Biother Radiopharm 25 2010 165 170
39. N. Nakaya, S.W. Lowe, Y. Taya, A. Chenchik, and G. Enikolopov Specific pattern of p53 phosphorylation during nitric oxide-induced cell cycle arrest Oncogene 19 2000 6369 6375 (Pubitemid 32641851)
40. M.J. Waterman, E.S. Stavridi, J.L. Waterman, and T.D. Halazonetis ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins Nat Genet 19 1998 175 178 (Pubitemid 28248801)
41. P.J. DiGregorio, J.A. Ubersax, and P.H. O'Farrell Hypoxia and nitric oxide induce a rapid, reversible cell cycle arrest of the Drosophila syncytial divisions J Biol Chem 276 2001 1930 1937 (Pubitemid 32109670)
42. J.E. Goodman, L.J. Hofseth, S.P. Hussain, and C.C. Harris Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease Environ Mol Mutagen 44 2004 3 9 (Pubitemid 38982068)
43. L.A. Porter, and D.J. Donoghue Cyclin B1 and CDK1: nuclear localization and upstream regulators Prog Cell Cycle Res 5 2003 335 347
44. J.P. Jeannon, and J.A. Wilson Cyclins, cyclin-dependent kinases, cyclin-dependent kinase inhibitors and their role in head and neck cancer Clin Otolaryngol 23 1998 420 424 (Pubitemid 28474982)